Lokivetmab

Showing 4 of 4 results
Lokivetmab is a monoclonal antibody used to treat allergic dermatitis and atopic dermatitis in dogs. It targets the cytokine interleukin-31 (IL-31), which plays a key role in itch and inflammation. Read more

Lokivetmab is a monoclonal antibody used to treat allergic dermatitis and atopic dermatitis in dogs. It targets the cytokine interleukin-31 (IL-31), which plays a key role in itch and inflammation.

Essential insights

  • Inhibition of IL-31: Lokivetmab specifically binds to IL-31, preventing its interaction with cell surface receptors. This reduces signaling responsible for itch and inflammation.
  • Reduction of Itch and Inflammation: By neutralizing IL-31, Lokivetmab rapidly alleviates itch and promotes healing of skin damage caused by chronic itching.
  • High Specificity: Lokivetmab is specifically designed to target canine IL-31 with minimal effects on other molecules or processes, reducing the risk of side effects.
Dog

Cytopoint (3 - 10 kg)

10 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
Dog

Cytopoint (10 - 20 kg)

20 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
Dog

Cytopoint (20 - 30 kg)

30 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
Dog

Cytopoint (30 - 40 kg)

40 mg/htgl Liquid for injection, solution (Vial)
2 x 1 pc, 6 x 1 pc
VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.